TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
SARomics Biostructures AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
19,278
|
17,765
|
16,646 |
Financial expenses |
13
|
376
|
63 |
Earnings before taxes |
631
|
1,813
|
1,231 |
EBITDA |
798
|
2,266
|
1,779 |
Total assets |
10,506
|
10,441
|
10,223 |
Current assets |
7,296
|
7,657
|
6,954 |
Current liabilities |
4,247
|
4,645
|
5,375 |
Equity capital |
5,908
|
5,397
|
4,400 |
- share capital |
91
![]() |
91
|
99 |
Employees (average) |
27
|
22
|
20 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
56.2%
|
51.7%
|
43.0% |
Turnover per employee |
714
|
808
|
832 |
Profit as a percentage of turnover |
3.3%
|
10.2%
|
7.4% |
Return on assets (ROA) |
6.1%
|
21.0%
|
12.7% |
Current ratio |
171.8%
|
164.8%
|
129.4% |
Return on equity (ROE) |
10.7%
|
33.6%
|
28.0% |
Change turnover |
1,421
|
2,467
|
2,763 |
Change turnover % |
8%
|
16%
|
20% |
Chg. No. of employees |
5
|
2
![]() |
2 |
Chg. No. of employees % |
23%
|
10%
|
11% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.